🇺🇸 FDA
Pipeline program

ziv-aflibercept

REGENERON-VGFT-ST-0202

Phase 1 mab completed

Quick answer

ziv-aflibercept for Cancer is a Phase 1 program (mab) at Regeneron UK Limited with 2 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Cancer
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials